BiliaryTractCancer near Bronx, NY

Biography: Dr. John Mascarenhas, MD is an Oncology Specialist who practices in New York, NY. He is 52 years old. Dr. John Mascarenhas, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Scott Nguyen, MD is a General Surgery Specialist who practices in New York, NY. He is 50 years old and has been practicing for 24 years. Dr. Scott Nguyen, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Marco B. Zoccali is a minimally invasive surgeon with extensive expertise in the treatment of the broad range of colorectal diseases including IBD, colon and rectal cancers, and benign colorectal diseases. He received his medical degree at the Catholic University in Rome, Italy where he also completed his surgical training. He then came to the USA where he did a Minimally Invasive Gastrointestinal Surgery Fellowship at the University of Chicago followed by a surgical residency at Weill Cornell Medical Center. He then completed his Colon and Rectal Surgery Fellowship at the University of Chicago. Although committed to managing the entire spectrum of pathologies that can affect the lower intestinal tract, his personal interest lies mostly in minimally invasive approaches to colorectal conditions including the robotic platform and the management of inflammatory bowel diseases. Beyond his clinical practice, Dr. Zoccali is also a prolific researcher. He has published more than 50 articles in major surgical journals including The Journal of The American College of Surgeons, The British Journal of Surgery and Inflammatory Bowel Disease, and has contributed to several book chapters.

Care Philosophy: I'm enthusiastic about providing each and every patient with the right treatment at the right time. I specialize in helping people with arthritic disorders of the hip and knee. After first attempting to treat you without surgery, it would be my pleasure to perform your primary knee or hip replacement or correct a failed or infected joint replacement. I'm also skilled at partial knee replacements, a much less invasive approach to treating knee arthritis before it has progressed to an advanced stage.

Care Philosophy: Our Lymphoma group has been at the forefront in the development of targeted therapies for CLL and other lymphoid malignancies. We strive to bring effective therapeutics to patients, years before they are widely available. I am fortunate to practice oncology in such an exciting era with rapidly improving diagnostic and therapeutic options. I seek to incorporate the latest breakthroughs and technology in providing care to my patients. Comprehensive in my approach, I am driven to understand the underlying biology of the disease, individualizing each patient's treatment plan. I offer patients a unique experience, with compassion for the patient and their family. With a large portfolio of clinical trials, our group offers ample opportunities for patients to participate in clinical research. Our hospital system is award winning and provides access to world-class consultants for all medical conditions. It will be a privilege to care for you or your family member.

Biography: Meghna S. Trivedi, MD, MS cares for patients diagnosed with breast cancer. Dr. Trivedi received her medical degree from the University of Maryland School of Medicine, and completed her residency at the University of Pennsylvania. She went on to complete her fellowship in hematology/oncology at Columbia University. Dr. Trivedi co-leads the Hereditary Breast and Ovarian Cancer Program, a comprehensive, multi-disciplinary initiative aimed at screening, preventing, diagnosing, and treating hereditary breast and ovarian cancer. This innovative program brings together the resources of a world-renowned academic institution, including cutting-edge genomic testing, clinical trials, and experts in hereditary cancers across different specialties. Dr. Trivedi's research and care expertise also includes cancer genetics and genomics, precision medicine, and chemotherapy induced peripheral neuropathy. She is the principal investigator on several clinical trials, and has authored numerous publications in leading peer-reviewed journals. Dr. Trivedi is a member of the American Society of Clinical Oncologists and SWOG.

Biography: Dr. Dawar Mahmood, MB BS is a General Surgery Specialist who practices in Astoria, NY. He is 75 years old and has been practicing for 52 years. Dr. Dawar Mahmood, MB BS is affiliated with Mount Sinai Queens.

Biography: Dr. Edward Chin, MD is a Bariatric Surgery Specialist who practices in New York, NY. He is 51 years old and has been practicing for 25 years. Dr. Edward Chin, MD is affiliated with Mount Sinai Hospital.

Biography: Michael S. Samuel, M.D. is an Assistant Professorof Clinical Medicine at Weill Cornell Medical College and Assistant Attending Physician at New York Presbyterian Hospital. Dr. Samuel took an indirect route to medicine, initially receiving his B.A. in English and Anthropology from Union College. He worked as a treatment counselor for developmentally disabled at-risk youth, and then as a teacher of English as a foreign language in Shenzhen, China.Dr. Samuel subsequently joined the leukemia program at Weill Cornell Medical College as a clinical trials research assistant while completing post-baccalaureate studies at Columbia University. He then received his MD from SUNY Downstate Medical Center College of Medicine in 2009. Thereafter, Dr. Samuel completed both his residency in internal medicine and fellowship in Hematology/Oncology at Montefiore Medical Center. His medical training also included experiences studying acupuncture in Beijing, China, and service as a physician on the medical ward at Kisoro District Hospital in Uganda.Throughout his medical training Dr. Samuel maintained a focus on hematological malignancies and spent his final year of fellowship in the lab of Kira Gritsman, MD, PhD, at Albert Einstein Cancer Center studying the genetic determinants of PI3 kinase pathway dependence in leukemic development. Dr. Samuel now rejoins the Leukemia Program in the division of Hematology/Oncology at Weill Cornell Medical College where he will specialize in the treatment of patients with leukemia, myelodysplasia and myeloproliferative neoplasms, and will be actively involved in the clinical trials research within the program.

Care Philosophy: I relate well to children of all ages in a non-threatening way. I will explain your child's condition in terms you can understand, and I will make sure that you understand all of the treatment options, including non-surgical options. I will answer all of your questions, and will make myself available to you, if you should have more questions after you leave. You will leave my office feeling educated and empowered. I will offer your child the latest in minimally invasive techniques, with minimal pain and scarring, and faster recovery. I love my patients and treat them as if they were my own, and I take pride in my craft.

Biography: Anton George Kelly, MD is an Assistant Professor of Surgery in the division of Trauma, Burns, Critical and Acute Care at Weill Cornell Medical College and Assistant Attending Surgeon at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Kelly specializes in Surgical Critical Care, Acute Care Surgery and Trauma with a focus on Traumatology and Burn management.Prior to his arrival, Dr. Kelly completed his residency in general surgery at Easton Hospital in Easton Pennsylvania followed by a dual fellowship in burn surgery and surgical critical care at New York-Presbyterian/Weill Cornell Medical Center and Westchester Medical Center respectively.Dr. Kelly is an active member of many prestigious medical and surgical societies, including the American College of Surgeons, Society of American Gastrointestinal and Endoscopic Surgeons, Society of Critical Care Medicine and the American Burn Association. He has also been published numerous peer-reviewed journal articles and abstracts.In addition, Dr. Kelly has been honored with the 2015 Physician of the Year Award from NewYork-Presbyterian/Weill Cornell Medical Center.

Biography: Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicineand a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.For More Videos, please see below:Lymphoma Cancer Treatment NY - Weill Cornell

Biography: Dr. James Lee is an internationally recognized endocrine surgeon who specializes in the care of patients with thyroid, parathyroid, and adrenal disorders. Dr. Lee is the Chief of Endocrine Surgery and the Edwin K. and Anne C. Weisskopf Professor of Surgical Oncology at Columbia University and the Physician Director of the Endocrine Service Line at the NY Presbyterian Hospital. He serves as Co-Director of the multidisciplinary Columbia Thyroid Center, Parathyroid Center, and Adrenal Center. He has been rated as one of the Best Doctors in America and is one of the highest volume endocrine surgeons in the country. Dr. Lee received his medical degree from Columbia University's College of Physicians and Surgeons, completed his residency in General Surgery at Columbia and went on to a fellowship in Endocrine Surgery at the University of California, San Francisco. Dr. Lee is actively involved in the leadership of Endocrine Surgery at the national and international level. He serves on the Executive Council of the American Association of Endocrine Surgeons and Standing Faculty of the international Endocrine Surgery University. He co-created the inaugural Postgraduate Course in Endocrine Surgery at the American College of Surgeons and is a featured lecturer in the biannual Masters of Endocrine Surgery Course. He has authored over 100 articles and book chapters, including the AAES Parathyroidectomy Guidelines which sets the international standard for the care of patients with parathyroid disease. He is also the Co-Editor of Surgical Endocrinopathies and the Founding Figures which details state of the art care for patients with endocrine disorders as well as the rich history of discovery in the field. Dr. Lee has given over 100 invited lectures and visiting professorships at institutions around the world. He has travelled extensively to teach other endocrine surgeons advanced techniques such as minimally invasive thyroid and parathyroid surgery as well as laparoscopic retroperitoneal adrenalectomy. He has mentored dozens of clinical and research fellows over his career, many of whom are now leaders in their own institutions and abroad. Dr. Lee also serves as the Vice Chair of New Media in the Columbia University Department of Surgery and Chair of the ColumbiaDoctors Communications Committee. In this role, he oversees the digital strategy for multiple groups across the medical center with the mission of providing the highest quality education on health and wellness to the global audience.

Care Philosophy: I treat each person as a unique individual. I get to know that person and listen to the medical issue(s) that led him/her to see me. I spend time in conversation and examination to gather the information necessary for a diagnosis and treatment. I discuss the management options so that we can jointly select the appropriate treatment. Every question is welcomed. I enjoy learning about each person and sharing the benefit of my expertise. I hold sacred the trust placed in my care.

Biography: James McKiernan, MD, is the John K. Lattimer Professor of Urology, and CEO, of ColumbiaDoctors. He also is the interim dean of Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues. For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.

Biography: Dr. Iwamoto is a neuro-oncologist whose previous training includes a neurology residency at NewYork-Presbyterian/Weill Cornell Medical Center and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. For over three years, Dr. Iwamoto was an attending physician and an investigator at the Neuro-oncology Branch, a trans-institute branch of the National Cancer Institute and National Institute of Neurological Disorders and Stroke, in Bethesda, MD. At the intramural NIH, Dr. Iwamoto was a principal investigator in early phase clinical trials for brain tumors and worked with laboratory and computational scientists on several translational projects in brain tumors. Dr. Iwamoto was recruited to Columbia University as the Deputy Director of the Neuro-oncology Division and is actively developing the clinical and translational research components of this program. He is an expert in the diagnosis, management, and treatment of brain and spinal cord tumors as well as neurological complications of cancer.